Literature DB >> 477719

3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.

N G Bacopoulos, S E Hattox, R H Roth.   

Abstract

The concentrations of dopamine (DA) metabolites (free and conjugated) was measured in plasma and brain regions of rats by the mass spectrometric method of selected ion monitoring. Experimental treatments which altered the function of central dopamine neurons also induced concomitant changes in plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Stimulation of the nigrostriatal pathway increased plasma DOPAC and HVA whereas lesion of the pathway decreased plasma metabolites. Several drug treatments induced parallel changes in brain and plasma concentrations of DA metabolites. It is suggested that changes in the concentration of DOPAC and HVA in rat brain are reflected by parallel changes in plasma. No conjugated forms of DOPAC and HVA were found in plasma and brain tissue of vervet monkeys (Cercopithecus aethiops).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477719     DOI: 10.1016/0014-2999(79)90175-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

2.  The adrenal contribution to the neuroendocrine responses to splanchnic nerve stimulation in conscious calves.

Authors:  S R Bloom; A V Edwards; C T Jones
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

3.  Mesocortical dopamine neurons: high basal firing frequency predicts tyrosine dependence of dopamine synthesis.

Authors:  S Y Tam; J D Elsworth; C W Bradberry; R H Roth
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.

Authors:  S C Wheeler; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

5.  Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain?

Authors:  M L Rao; B Strebel; G Gross; G Huber
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

6.  Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.

Authors:  Tomiki Sumiyoshi; A Roy; C-H Kim; K Jayathilake; M A Lee; C Sumiyoshi; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

7.  Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples.

Authors:  H M Thiede; W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

8.  Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates.

Authors:  J D Elsworth; D J Leahy; R H Roth; D E Redmond
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.